Predictive data to preserve health

Delivering and exploiting data for cardiac decompensation prevention

Our mission

Providing actionable data to maintain cardiac condition stability

Keep patients at home

Delay the loss of autonomy

Reduce avoidable hospital admissions

At CardiaMetrics, we want to provide telemedicine platforms and physicians with early data to prevent cardiac decompensations and adjust medications to maintain the stability of the cardiac function.

This solution addresses chronic heart failure patients and those undergoing cardiotoxic drugs for cancer treatment.

Heart failure burden

64 million people worldwide

1 in 5 people aged 70-85 years have HF

 1,270,360  hospitalizations / year (in 2018)

$30.7 billion in 2012 to 69.7 billion in 2030

Our Solution

A best-of-breed medical monitoring system utilizing subcutaneous sensors that collect and transmit vital physiological data daily.

This IoT-enabled solution provides combined and aggregated hemodynamic and electrophysiological data to remote monitoring platforms, enabling proactive and personalized patient care by giving clinicians regular, remote insights into key biological metrics.

Additionally, our solution allows for the identification and prioritization of individuals who require immediate intervention or preventive therapeutic adjustments, thereby increasing the productivity of healthcare teams by streamlining workflows and focusing resources where they are needed most.

Our Solution
Our Solution

Creating a meaningful impact

For healthcare system

Enlarge market and allow scalability

  • Increasing efficiency thanks to daily and reliable data
  • Prioritizing patients at risk to reduce time waste, allowing to take care of more individuals
  • Expanding the accessible Market with a solution suitable for patients who can’t or don’t want to engage in self-care management

For patients

Ensure Stability and provide personnalized care

  • Avoiding crises by early optimization of treatments
  • Decreasing the mental burden of the disease by providing a fully automatic solution
  • Patient empowerment through effective therapeutic education personalized with his own data

Coming Soon

We are about to launch our first human trial in partnership with the Caen hospital (Normandy, France).

Latest News

Thibault Parmentier, Co-Founder of CardiaMetrics, Named 2024 Laureate of Réseau Entreprendre® Isère

We are thrilled to announce that Thibault Parmentier, co-founder of...

CardiaMetrics successfully closes initial funding round of €300K

  We are excited to announce that CardiaMetrics has successfully...

JFIC’2024 celebrated the first year of telemonitoring reimbursement in France

Francophone Days of Heart Failure provided the opportunity to the founders of...

Cordella™ acquisiton by Edwards Lifesciences

Exciting Milestones for Endotronics, Heart Failure Monitoring Medtech company,...